ISSN: 2329-6917
Rehab Al-blooshi, Dimitrios Vergidis and Jeffrey H Lipton
We report a case of a young male with chronic phase CML who despite achieving an excellent response to dasatinib therapy, developed isolated CNS blast crisis even though this tyrosine kinase inhibitor is the only one reported to cross the blood brain barrier.